Back to search

Article

Renal Outcomes and Dosage Considerations Associated with Bisphosphonate Use: A Systematic Review of Randomized Clinical Trials

2026-05-18

Abstract excerpt

<title>Abstract</title> <p> Background Though bisphosphonates are the gold standard for the treatment of different metabolic bone disorders including osteoporosis for more than five decades, their safety and tolerability in patients with compromised kidney function are not well known. With age-related bone disorders and renal insufficiency becoming more prevalent worldwide, understanding the effect of bisphosph...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
51ed9817-105b-5962-8d94-8be486b9d6a8
DOI
10.21203/rs.3.rs-9724722/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Renal Outcomes and Dosage Considerations Associated with Bisphosphonate Use: A Systematic Review of Randomized Clinical TrialsDOI 10.21203/rs.3.rs-9724722/v1
Effectivity and Safety Profile of Tenapanor, a Sodium-Hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease, a Systematic Review of Clinical StudiesSemantic proximity
Nephrolithiasis-associated bone disease: pathogenesis and treatment options.Semantic proximity
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World DataSemantic proximity
Hyperphosphatemia in Patients with Chronic Kidney Disease (CKD)Semantic proximity
Analysing the impact of a guideline for the use of new potassium binders for treatment of chronic hyperkalaemia to maximise inhibition of renin–angiotensin–aldosterone system (RAAS) within the general nephrology clinic?Semantic proximity
Top 50 cited articles on the treatment of chronic kidney disease: a bibliometric analysisSemantic proximity
Use of drugs with Pharmacogenomics (PGx)-Based Dosing Guidelines in a Danish Cohort of Persons with Chronic Kidney Disease, Both on Dialysis and Not on Dialysis: Perspectives for Prescribing OptimizationSemantic proximity
Drugs Associated with Urinary Retention Adverse Reactions: A Joint Analysis of FDA Adverse Event Reporting System and Mendelian Randomization.Semantic proximity
Appropriateness of Ketoanalogues of Aminoacids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA ConsensusSemantic proximity
The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: Protocol for a Systematic Review.Semantic proximity
Electrolyte Disorders Induced by Multikinase Inhibitors Therapy for Renal Cell Carcinoma：A Large-Scale Pharmacovigilance AnalysisSemantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Select a neighboring publication to make it the new centre.